2[2]COOK G A,THIM L,YEOMANS N D,et al.Oral human spasmolytic polypeptide protects against aspirin-induced gastric Injury in rast[J].J Gastroenterol Hepatol,1998,13(4):363.
6[6]LEUNG W K,YU J,CHAN F K,et al.Expression of trefoil peptides (TFF-1,TFF-2 and TFF-3) in gastric carcinomas, intestinal metaplasia,and non-neoplastic gastric tissue[J].J pathol,2002,197(5):582.
7[7]SUAREZ C,VIZOSO F,RODRIGUEZ JC,et al.Prognostic significance of cytosolic PS2 protein content in gastric cancer[J].Int J Biol Markers,2001,16(1):37.
9[9]LEFEBVRE O,CHENARD M P,MASSON R,et al.Gastric mucosal abnormalities and tumorigenesis in mice lacking the PS2 trefoil protein[J].Science,1996,274(5285):259.
10[10]AZARSCHAB P,AlAZZEH E,KORNBERGER W,et al.Aspirin promotes TFF2 gene activation in human gastric cancer cell lines [J].FEBS Lett,2001,488(3):206-210.
2Sands B E, Podolsky D K. The trefoil peptide family. Annu Rev Physiol,1996,58 : 263-273.
3Thompson W G. Diagnostic criteria for functional gastrointestinal disorders In:Roma Ⅱ : the functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment : a multinational consensns. 2nd ed. VA. Degnon Associates Mclean USA,2000.659-668.
4Jorgensen K H, ThimL, Jacobsen H E, Pancreatic spasmalytic polypeplide(PSP) : I. preparation and initial chemical characterization of a new polypeptide form procine pancreas. Regul Pept, 1982,3(3 - 4) :207-219.
5Hauser F, Poulsom R,Chinery R, et al. Hpl. B. a human p-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcerassociated cell lineage and the uterus. Prec Nail Acad Sci USA, 1993,90( 15 ) : 6961-6965.
6Dignass A, Lynch Devaney K,Kindon H, et al. Trefoil peptides promote epithelial migration through a transforming grouwth factor β-independent pathway. J Clin Invest, 1994,94 ( 1 ) : 376-383.
8J L Newton,A Allen,B R Wesfley,et al. The human trefoil peptide,TFF1 ,is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut 2000;46:312-320.
9Joo YE, Sohn YH, Joo SY, et al. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer [J]. Korean J Intern Med,2002,17(4) :211.
10Rodrigurs S, Van Aken E, Van Bocxlaer S, et al. Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling [J]. FASEB J,2003,17( 1 ) :7.
